Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LSINCT5
   Synonyms NA
   Region GRCh38_5:2712591-2715237    Sequence
   Ensembl NA
   RefSeq NR_145480
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name breast cancer
   ICD-0-3 C50  
   Methods qPCR
   Sample breast cancer tissues
   Expression Pattern differential expression
   Function Description

The expression levels of both genes was lower in the overweight-obese (BMI â?¥ 25) subgroup than that in the normal BMI (BMI < 25) subgroup (GAS5 P = .019, LSINCT5 P = .036). Moreover, the expression level of GAS5 was negatively correlated with BMI (r: _x0001_.170, P: .041). The expression level of GAS5 was higher in women with late menarche (>13 years) than that with early menarche (â?¤13 years; P = .017).

   Pubmed ID 29785740
   Year 2018
   Title Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity
   External Links
   Links for  LSINCT5 GenBank       HGNC       lncrnadb       Noncode
   Links for  breast cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.